209 related articles for article (PubMed ID: 16961291)
21. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy.
Nicastri PL; Diaferia A; Tartagni M; Loizzi P; Fanelli M
Br J Obstet Gynaecol; 1998 Nov; 105(11):1205-7. PubMed ID: 9853771
[TBL] [Abstract][Full Text] [Related]
22. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
Binder T; Salaj P; Zima T; Vítek L
J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Parízek A; Simják P; Cerný A; Sestinová A; Zdenková A; Hill M; Dusková M; Vlk R; Kokrdová Z; Koucký M; Vítek L
Ann Hepatol; 2016; 15(5):757-61. PubMed ID: 27493115
[TBL] [Abstract][Full Text] [Related]
24. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
Kawakita T; Parikh LI; Ramsey PS; Huang CC; Zeymo A; Fernandez M; Smith S; Iqbal SN
Am J Obstet Gynecol; 2015 Oct; 213(4):570.e1-8. PubMed ID: 26071912
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
Marschall HU
Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
[No Abstract] [Full Text] [Related]
26. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
27. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
29. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
Gümüş Güler B; Özler S
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):271-276. PubMed ID: 31919038
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy.
Laifer SA; Stiller RJ; Siddiqui DS; Dunston-Boone G; Whetham JC
J Matern Fetal Med; 2001 Apr; 10(2):131-5. PubMed ID: 11392594
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience.
Zapata R; Sandoval L; Palma J; Hernández I; Ribalta J; Reyes H; Sedano M; Tohá D; Silva JJ
Liver Int; 2005 Jun; 25(3):548-54. PubMed ID: 15910492
[TBL] [Abstract][Full Text] [Related]
32. Clinical grading of intrahepatic cholestasis pregnancy.
Pradhan M; Shao Y
JNMA J Nepal Med Assoc; 2013; 52(190):413-9. PubMed ID: 24362672
[TBL] [Abstract][Full Text] [Related]
33. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
Mikucka-Niczyporuk A; Pierzynski P; Lemancewicz A; Kosinski P; Charkiewicz K; Knas M; Kacerovsky M; Blachnio-Zabielska A; Laudanski P
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106399. PubMed ID: 31733339
[TBL] [Abstract][Full Text] [Related]
34. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
[TBL] [Abstract][Full Text] [Related]
35. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
Jain P
J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
[No Abstract] [Full Text] [Related]
36. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
37. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy].
Zhou F; Gao B; Wang X; Li J
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):299-304. PubMed ID: 25173231
[TBL] [Abstract][Full Text] [Related]
38. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
[No Abstract] [Full Text] [Related]
39. Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby.
Carey EJ; White P
Evid Based Med; 2013 Dec; 18(6):e55. PubMed ID: 23635844
[No Abstract] [Full Text] [Related]
40. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
